期刊文献+

骨化三醇干预骨质疏松对高脂血症血管钙化的影响 被引量:4

Effect of calcitriol treating osteoporosis on vascular calcification in hyperlipidemia
下载PDF
导出
摘要 目的探讨通过采用骨化三醇干预骨质疏松,对高脂血症导致的血管钙化的影响。方法选择2010年5月~2011年4月在我院进行治疗的高脂血症患者80例为研究对象,分为研究组和对照组各40例。对照组采用阿托伐他汀降血脂治疗,研究组在此基础上加用骨化三醇治疗。测定治疗前后两组颈动脉斑块的人数及斑块厚度、心脏瓣膜钙化的比例、肱动脉到胫后动脉的脉搏波速度。结果颈动脉钙化斑厚度研究组治疗后与治疗前比较差异显著(P<0.05),治疗后两组间比较差异具有统计学意义(P<0.05)。踝臂脉搏波传导速度对照组与研究组治疗前后组内比较,差异均有统计学意义(P<0.01),研究组治疗后低于对照组(P<0.01)。结论对高血脂合并骨质疏松症患者在降血脂治疗的基础上加用骨化三醇干预骨质疏松,能够改善血管钙化情况。 Objective To discuss effect of calcitriol treating osteoporosis on vascular calcification in hyperlipidemia. Methods May 2010 to Apr 2011, 80 cases with hypedipidemia were selected as subjects. They were divided into study group and control group randomly (40 cases in each). Control received atorvastatin treatment . Study received calcitriol based on control group. Cases with carotid atherosclerotic plaque, plaque thickness, cases with cardiac valve calcification, and pulse wave velocity from brachial artery to the posterior tibia1 artery were compared. Results Plaque thickness in study after treatment were significantly different with before treatment (P 〈 0.05), which had significant different between study group and control group after treatment too(P 〈 0.05). Pulse wave velocity after treatment in two groups was lower than before treatment(P 〈 0.01); And study group after treatment was lower than control group (P 〈 0.01). Condlusion Based on Lipid-lowering therapy on hyperlipidemia, combined With calcitriol in treatment of osteo- porosis, can improve vascular calcification.
作者 周德安
出处 《中国现代医生》 2013年第9期20-21,24,共3页 China Modern Doctor
关键词 骨化三醇 骨质疏松 高脂血症 血管钙化 Calcitriol Osteoporosis Hyperlipidemia Vascular calcification
  • 相关文献

参考文献10

二级参考文献87

  • 1武玮,王淑荣,张巍.经玻璃紫外线照射对大鼠25-羟维生素D水平及骨代谢的影响[J].中国当代儿科杂志,2009,11(2):138-141. 被引量:3
  • 2程翔,廖玉华.炎症与动脉粥样硬化[J].中华心血管病杂志,2004,32(5):475-477. 被引量:87
  • 3徐大立,刘颖,范永华,王燎,陶以嘉.急性心肌梗死的研究进展[J].心血管病学进展,2005,26(B08):86-92. 被引量:9
  • 4中华人民共和国卫生部.婴幼儿佝偻病防治方案[J].中华儿科杂志,1986,24(6):367-367.
  • 5黎磊石,刘志红主编.中国肾脏病学[M].北京:人民军医出版社,2008,1328-1338
  • 6中华人民共和国卫生部.药物临床研究指导原则[M].北京:人民卫生出版社,1998.86-88.
  • 7Laen JM,Igiley EH,Wirganowicz PZ Osteoporosis.diagnosis and treatment[J].lnstr Course Lect,1997,46.445-458.
  • 8Aloia JF,Arunabh-TalwarS,Pollack S,et al. The remodeling transient and the calcium economy. Osteoporos Int,2008,19(7).1001--1009.
  • 9CheungR,ErclikMS,Mitchell J.1,25-dihydroxyVitamin D3stimulated protein kinase C phosphorylation of typeVladenyly cyclase inhibits parathyroid hermone signal transduction in rat osteoblastic UNE 106-Olcel[J]. J Cellbiochem,2005,94(5):1017-1027.
  • 10Aerssens J,Audekercke RV,Talalaj M,et al.Effect of 1-vitamin D3 and estrogen therapy on cortical bone mechanical properties in the ovariectomized rat model J Endocrinol, 1996,137(4):1358-1364.

共引文献1881

同被引文献23

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部